imipramine has been researched along with Consciousness, Loss of in 2 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thiemann, HH | 1 |
| Otto, L | 1 |
| Fritz, H | 1 |
| Itil, T | 1 |
| Fink, M | 1 |
2 other studies available for imipramine and Consciousness, Loss of
| Article | Year |
|---|---|
[Fatal poisoning with imipramine].
Topics: Electrocardiography; Heart; Humans; Imipramine; Infant; Male; Respiration; Spasm; Unconsciousness | 1967 |
EEG and behavioral aspects of the interaction of anticholinergic hallucinogens with centrally active compounds.
Topics: Acridines; Adolescent; Adult; Atropine; Behavior; Chlorpromazine; Consciousness; Dextroamphetamine; | 1968 |